Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Explore the best Visa credit card with rewards and no annual fee. Enjoy effortless earning on every transaction you make.
9,364 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
As Shake Shack charts a path into 2025, investors seek clarity on margins, store growth, and digital momentum. This g...
Bitcoin headlines often swing between hype and fear. This article explores a cathie wood invest just approach to calm...
Novo Nordisk stock faced renewed selling pressure this week as investors weighed trial results and government-driven ...
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Apple's pivot toward services could change how the stock is valued. This guide breaks down the thesis, risks, and a p...
Institutional funds often reveal conviction through large stake increases. This article explains the implications whe...
After Microsoft's pullback, savvy investors look for durable megacap ideas. This guide highlights three top megacap s...
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Philip Morris International is steering a bold pivot toward smoke-free products, aiming to drive more than two-thirds...
A confident march for Nvidia stock could hinge on one powerful trend. This article breaks down the single reason reas...
Geopolitical tensions push oil higher, sparking a potential wave of higher gas prices and new bets in energy markets....